** Shares of home-based healthcare provider Enhabit Inc
EHAB.N up 3.6% at $14.20
** Brokerage Stifel initiates coverage on the stock with
"buy" rating and PT of $17
** Enhabit has built scale and density as a top home health
services provider in half of the 34 states it operates in -
Stifel
** Through acquisition as well as co-locating hospice
services, company grew revenue and adj EBITDA by 14% and 17%,
respectively, from 2015 to 2021, says brokerage
** Stifel, however, notes plenty of operating challenges for
company in near term
** 2 of 6 brokerages rate stock "buy" or higher, 3 "hold", 1
"sell"; median PT is $17 - Refinitiv
** Including session's move, stock down 45.3% since its June
IPO
(Reporting by Pratik Jain in Bengaluru)
((Pratik.Jain@thomsonreuters.com))